GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
14.89
-0.46 (-3.00%)
Dec 5, 2025, 4:00 PM EST - Market closed
GH Research Market Cap
GH Research has a market cap or net worth of $923.62 million as of December 5, 2025. Its market cap has increased by 87.46% in one year.
Market Cap
923.62M
Enterprise Value
630.31M
1-Year Change
87.46%
Ranking
Category
Stock Price
$14.89
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has increased from $808.33M to $923.62M, an increase of 14.26%. That is a compound annual growth rate of 3.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 952.15M | 161.44% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |